Zobrazeno 1 - 10
of 94
pro vyhledávání: '"Yan Yan Yin"'
Publikováno v:
Journal of Neuroinflammation, Vol 17, Iss 1, Pp 1-11 (2020)
Abstract Background Dry skin itch is one of the most common skin diseases and elderly people are believed to be particularly prone to it. The inflammasome has been suggested to play an important role in chronic inflammatory disorders including inflam
Externí odkaz:
https://doaj.org/article/c98fc99ace244ab0855447564d3e997b
Autor:
Bo Gao, Yu Wu, Yuan-Jian Yang, Wei-Zu Li, Kun Dong, Jun Zhou, Yan-Yan Yin, Da-Ke Huang, Wen-Ning Wu
Publikováno v:
Journal of Neuroinflammation, Vol 15, Iss 1, Pp 1-12 (2018)
Abstract Background Epilepsy is a common neurological disorder and is not well controlled by available antiepileptic drugs (AEDs). Inflammation is considered to be a critical factor in the pathophysiology of epilepsy. Sinomenine (SN), a bioactive alk
Externí odkaz:
https://doaj.org/article/6fc3029323714ae287c5094a3f264622
Publikováno v:
Tungsten. 5:109-117
Publikováno v:
Ceramics International. 48:19098-19108
Publikováno v:
Rare Metals. 41:2292-2304
Publikováno v:
Scripta Materialia. 234:115541
Publikováno v:
Nanoscale. 14:15897-15907
Molecular complexes based on Cu or Zn were selected as heterogeneous catalysts for efficient and stable Knoevenagel condensation and CO2 cycloaddition. DFT demonstrated that the change in coordination mode accelerates the reactions.
Publikováno v:
Canadian Journal of Physiology and Pharmacology. 99:1298-1307
Biochanin A (Bioch A) is a natural plant estrogen, with various biological activities such as anti-apoptosis, anti-oxidation, and suppression of inflammation. In this study, we investigated the protective effects of Bioch A on angiotensin II (AngII)
Effect of dapagliflozin on diabetic patients with cardiovascular disease via MAPK signalling pathway
Autor:
Zhao-Di Yue, Yi-Bo Liu, Ren-Jie Zhao, Fangqi Wang, Shao-Hong Yu, Zhongwen Zhang, Yi Ding, Bing-Yu Du, Yan-Yan Yin, Li Li, Hui Fu
Publikováno v:
Journal of Cellular and Molecular Medicine
Clinical studies have shown that dapagliflozin can reduce cardiovascular outcome in patients with type 2 diabetes mellitus (T2DM), but the exact mechanism is unclear. In this study, we used the molecular docking and network pharmacology methods to ex
Publikováno v:
Materials Letters. 334:133747